VeriTeQ Corporation Rebrands Its “Q Inside Smartmarker” To Lead Its Radiation Dosimetry Business; Q Inside Smart Marker Is World’s First Implantable Sensor Cleared By FDA To Measure Radiation Dose Directly At The Tumor Site

DELRAY BEACH, Fla.--(BUSINESS WIRE)--VeriTeQ Corporation (“VeriTeQ” or “Company”) (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it is rebranding its Q Inside SmartMarker to lead its radiation dosimetry business. Q Inside SmartMarker (previously known as DVS SmartMarker®) is the only FDA- cleared implantable radio frequency (“RF”) radiation sensor that provides localization of a tumor and measures radiation dose at the tumor site. VeriTeQ’s radiation dosimetry products have six FDA clearances and CE approvals, and the Company has over 100 patents, patents pending, and exclusive licenses.

Help employers find you! Check out all the jobs and post your resume.